Moreover, tumor cells might sort ATP7B using molecular machineries/mechanisms that differ from those in hepatocytes and, hence, could be selectively targeted to suppress ATP7B-mediated resistance to cisplatin (see below). The gene discussed is ATP7B; the disease is neoplasm.